About US
Contact us
-
AstraZeneca sharpens Imfinzi's lung cancer edge with big survival winAstraZeneca already has an OK to market Imfinzi for stage 3 lung cancer that can't be surgically removed. But just-unveiled survival data will strengthen its case—and its lead over its immuno-oncology2018/9/27
-
EMA feeling better about drug supply interruptions from BrexitThe European Medicines Agency says concerns over drug shortages stemming from Brexit have eased, but not all drugmakers feel the same. The EMAreportedthis week that it has revised its list of drugs w2018/9/27
-
Takeda and Molecular Templates partner on protein-based cancer therapyTakeda Pharmaceutical has signed a licence, development and commercialisation agreement with drug development firm Molecular Templates to co-develop protein-based treatments for cancer. The partners2018/9/26
-
Pharma Technology Focus – Issue 75Pharma Technology Focus is now available on all devices.Read it for freehere. Researchers from the University of Toronto have published an overview of clinical trial and health data transparency acro2018/9/26
-
NHS wins landmark ruling against pharma companies over AMD drugThe UK High Court has ruled in favour of the NHS regarding the use of a cheaper, unlicensed drug for common eye condition wet age-related macular degeneration (AMD) over the much more expensive treatm2018/9/25
-
Amicus Therapeutics to buy Celenex for $100m upfrontUS-based biotechnology firm Amicus Therapeutics has entered into a definitive agreement to buy clinical stage gene therapy firm Celenex for $100m in an upfront payment. The transaction will fetch Ami2018/9/25
-
New compounds may prevent spread of malariaResearchers at Imperial College London have discovered compounds that can potentially prevent malaria parasites from infecting mosquitoes, which could in turn avoid the spread of the disease to humans2018/9/21
-
Novo Nordisk to lay off 400 employees in Denmark and ChinaNovo Nordisk has announced plans to lay off around 400 staff in research and development (R&D) roles at its China and Denmark sites as part of its R&D restructuring strategy. The restructurin2018/9/21
-
NIAID and Children’s National boost paediatric clinical research allianceNational Institute of Allergy and Infectious Diseases (NIAID), a unit of the National Institutes of Health (NIH), has strengthened a clinical research partnership with the Children’s National Health S2018/9/20
-
Cancer Research UK launches new research hub for biotherapeuticsCancer Research UK has launched a global centre of excellence in London to facilitate research on biotherapeutics as a treatment option for cancer. The new Cancer Research UK City of London Centre ha2018/9/20